Macquarie Group’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.09M | Hold |
379,100
| – | – | ﹤0.01% | 1093 |
|
|
2025
Q1 | $2.98M | Hold |
379,100
| – | – | ﹤0.01% | 1109 |
|
|
2024
Q4 | $5.65M | Hold |
379,100
| – | – | 0.01% | 924 |
|
|
2024
Q3 | $5.8M | Hold |
379,100
| – | – | 0.01% | 934 |
|
|
2024
Q2 | $5.77M | Hold |
379,100
| – | – | 0.01% | 940 |
|
|
2024
Q1 | $7.16M | Hold |
379,100
| – | – | 0.01% | 883 |
|
|
2023
Q4 | $7.24M | Hold |
379,100
| – | – | 0.01% | 886 |
|
|
2023
Q3 | $6.81M | Hold |
379,100
| – | – | 0.01% | 863 |
|
|
2023
Q2 | $7.7M | Hold |
379,100
| – | – | 0.01% | 848 |
|
|
2023
Q1 | $6.92M | Hold |
379,100
| – | – | 0.01% | 875 |
|
|
2022
Q4 | $7.84M | Sell |
379,100
-758
| -0.2% | -$15.7K | 0.01% | 887 |
|
|
2022
Q3 | $9.94M | Sell |
379,858
-22
| -0% | -$576 | 0.01% | 829 |
|
|
2022
Q2 | $9.63M | Hold |
379,880
| – | – | 0.01% | 873 |
|
|
2022
Q1 | $12K | Hold |
379,880
| – | – | 0.01% | 892 |
|
|
2021
Q4 | $15.4M | Sell |
379,880
-82,100
| -18% | -$3.32M | 0.01% | 833 |
|
|
2021
Q3 | $16.1M | Sell |
461,980
-1,418
| -0.3% | -$49.4K | 0.01% | 820 |
|
|
2021
Q2 | $12.7M | Hold |
463,398
| – | – | 0.01% | 880 |
|
|
2021
Q1 | $13M | Buy |
463,398
+1,034
| +0.2% | +$29K | 0.02% | 654 |
|
|
2020
Q4 | $12M | Hold |
462,364
| – | – | 0.02% | 655 |
|
|
2020
Q3 | $7.93M | Buy |
462,364
+61,200
| +15% | +$1.05M | 0.01% | 704 |
|
|
2020
Q2 | $9.93M | Buy |
+401,164
| New | +$9.93M | 0.02% | 634 |
|